Blackstone and Ferring pump $570m into bladder cancer gene therapySwitzerland’s Ferring Pharmaceuticals has joined with US investor Blackstone Life Sciences to pump $570 million into a bladder Share XBlackstone and Ferring pump $570m into bladder cancer gene therapyhttps://pharmaphorum.com/news/blackstone-and-ferring-pump-570m-into-bladder-cancer-gene-therapy/
